Outcomes of elacestrant in patients with ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer who received prior endocrine therapy and cyclin-dependent kinase inhibitor in a real-world setting
- DOI
- 10.1016/j.esmoop.2026.108535
- Published
- 2026-10
- Container
- ESMO Open
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.108535,
title = {Outcomes of elacestrant in patients with ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer who received prior endocrine therapy and cyclin-dependent kinase inhibitor in a real-world setting},
author = {G. Curigliano and M. De Laurentiis and N. Harbeck and S. Kuemmel and J.Á. García-Sáenz and R. Sanchez Bayona and D. Rea and A. Okines and B. Pistilli and E. Sears and J. Maitland and S. Kloss and T. Wasserman and M. Ignatiadis},
year = {2026},
journal = {ESMO Open},
doi = {10.1016/j.esmoop.2026.108535},
url = {https://doi.org/10.1016/j.esmoop.2026.108535}
}RIS
TY - JOUR TI - Outcomes of elacestrant in patients with ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer who received prior endocrine therapy and cyclin-dependent kinase inhibitor in a real-world setting AU - G. Curigliano AU - M. De Laurentiis AU - N. Harbeck AU - S. Kuemmel AU - J.Á. García-Sáenz AU - R. Sanchez Bayona AU - D. Rea AU - A. Okines AU - B. Pistilli AU - E. Sears AU - J. Maitland AU - S. Kloss AU - T. Wasserman AU - M. Ignatiadis PY - 2026 JO - ESMO Open DO - 10.1016/j.esmoop.2026.108535 UR - https://doi.org/10.1016/j.esmoop.2026.108535 ER -
APA
Curigliano, G., Laurentiis, M. D., Harbeck, N., Kuemmel, S., García-Sáenz, J., Bayona, R. S., Rea, D., Okines, A., Pistilli, B., Sears, E., Maitland, J., Kloss, S., Wasserman, T., & Ignatiadis, M. (2026). Outcomes of elacestrant in patients with ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer who received prior endocrine therapy and cyclin-dependent kinase inhibitor in a real-world setting. ESMO Open. https://doi.org/10.1016/j.esmoop.2026.108535
Source records
- crossref · retrieved 2026-09-25T06:47:56.211Z